Money Is Moving

Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Inwentash buying at Avicanna (T:AVCN)

Updated Monday Nov 28, 2022 03:18 AM EDT

Sheldon Inwentash, a 10% Holder, acquired 1,959,000 Common Shares on a direct ownership basis at prices ranging from $0.272 to $0.290 between November 23rd, 2022 and November 25th, 2022. This represents a $538,068 investment into the company's shares and an account share holdings change of 74.1%.

Avicanna is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Avicanna Inc. is a Canada-based commercial-stage biopharmaceutical company. The Company is engaged in cannabinoid research, development, and evidence-based products for the global medical and pharmaceutical market segments. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis & Wellness Products and Pharmaceutical Pipeline. Its Medical Cannabis & Wellness Products are marketed under the RHO Phyto brand and are a line of pharmaceutical-grade cannabis products containing varying ratios of cannabidiol (CBD) and tetrahydrocannabinol (THC). Avicanna has created a pipeline of patent-pending drug candidates that are indication-specific and in various stages of clinical development and commercialization. These cannabinoid-based drug candidates look to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders.

INK Edge Outlook

6 months ago
1 year ago
The INK Edge Outlook is a quantitative process that ranks a stock based on our V.I.P. criteria.
View outlooks on all Canadian listed stocks at
Two-week free trial for first time users.
Go to Avicanna Inc. (AVCN)'s company page

Comment On!

Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to (via Easy Blurb).

Comment On!

No Comments


Search (past week) for $AVCN.CA

  • No tweets found